Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
NanoString Forges Closer Ties With Broad Institute to See What Genetic Tool Can Really Do
|
Luke Timmerman |
11/18/09 |
Seattle
|
|
Bing Partners with Wolfram Alpha, OVP Leads $30M Fate Deal, Redfin Rakes In $10M, & More Seattle-Area Deals News
|
Gregory T. Huang |
11/17/09 |
Seattle
|
|
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells
|
Luke Timmerman |
11/16/09 |
National
|
|
Hamilton Thorne Raises $2.2M
|
Wade Roush |
11/10/09 |
Boston
|
|
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region
|
Luke Timmerman |
11/10/09 |
San Diego
|
|
TEDMED Sessions Seek the Patterns in Health Care and Life Sciences That Hold Ideas Together
|
Bruce V. Bigelow |
10/28/09 |
San Diego
|
|
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/22/09 |
Seattle
|
|
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key
|
Luke Timmerman |
10/18/09 |
National
|
|
Omeros Teed Up for IPO Next Week, Seeking to Rake In More Than $80M
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
Sequenom Starts Over After Purge, Patent Lawsuits Flying Over Gene Sequencing Technologies, Zogenix Prepares for Needle-Free Injections, & More San Diego Biotech News
|
Bruce V. Bigelow |
10/01/09 |
San Diego
|
|
Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology
|
Luke Timmerman |
09/30/09 |
National
|
|
From Academics to Biotech: A Journey to the Supposed “Dark Side”
|
Charlotte Hubbert |
09/28/09 |
Seattle
|
|
Ascent Therapeutics’ Blood Cancer Drug Could Rival Genzyme’s Mozobil
|
Ryan McBride |
09/16/09 |
Boston
|
|
SEC Charges CellCyte With Stem Cell Fraud
|
Luke Timmerman |
09/08/09 |
Seattle
|
|
Genzyme’s Mozobil Gets European Approval
|
Ryan McBride |
08/05/09 |
Boston
|
|
UW Stem Cell Startup is Born, Global Health’s “Davos” Arrives, MDRNA Unloads Debt, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
Nobel Laureate Mario Capecchi Encourages Postdocs, and Third Graders, To “Dream Big”
|
Eric Hal Schwartz |
06/15/09 |
Seattle
|
|
UW Spinout, Beat BioTherapeutics, Aims to Make Stem Cells for Damaged Hearts
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
Novocell Snaps Up Second Stem Cell Patent, New CEO Pursues “Next Big Field” of Biotech
|
Luke Timmerman |
06/03/09 |
San Diego
|
|
Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants
|
Ryan McBride |
05/27/09 |
San Diego
|
|
Stem Cell Tech in Fate’s Hands
|
Ryan McBride |
05/15/09 |
San Diego
|
|
Novocell Hires John West as CEO
|
Luke Timmerman |
05/11/09 |
San Diego
|
|
Cytori Expands GE Partnership; Raises More Cash
|
Bruce V. Bigelow |
05/08/09 |
San Diego
|
|
Novocell Gets $5.4M State Grant
|
Bruce V. Bigelow |
04/30/09 |
San Diego
|
|
Fate Therapeutics and Stemgent Team Up to Offer Stem Cell Advances to the Research Market
|
Ryan McBride |
04/23/09 |
San Diego
|
|
The Obama Bounce & San Diego’s Cleantech Innovators, Zeebo Steps Onto A Global Stage, Hollis-Eden Axes Its Namesake Founder, & More SD BizTech News
|
Bruce V. Bigelow |
03/30/09 |
San Diego
|
|
Salk Forms Stem Cell Partnership With Sanofi-Aventis
|
Bruce V. Bigelow |
03/26/09 |
San Diego
|
|
Cytori Raises $10 Million
|
Bruce V. Bigelow |
03/16/09 |
San Diego
|
|
Obama’s Stem Cell Reversal Sparks Deals, Qualcomm’s MediaFLO Revealed, Nokia’s Wireless Mapping, & More SD BizTech News
|
Bruce V. Bigelow |
03/16/09 |
San Diego
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
